Repligen (RGEN) EBT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Repligen (RGEN) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -211.00 |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 1,575.00 |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 3,000.00 |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -138.00 |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -730.00 |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 30,357.00 |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -871.00 |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 2,904.00 |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -1,462.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -871.00 |
| Mar 31, 2026 | -1,031.00 |
| Dec 31, 2025 | -683.00 |
| Sep 30, 2025 | -1,458.00 |
| Jun 30, 2025 | -1,879.00 |
| Mar 31, 2025 | -2,386.00 |
| Dec 31, 2024 | -7,890.00 |
| Sep 30, 2024 | -2,388.00 |
| Jun 30, 2024 | -2,154.00 |
| Mar 31, 2024 | -2,076.00 |
| Dec 31, 2023 | 245.00 |
| Sep 30, 2023 | -1,080.00 |
| Jun 30, 2023 | -267.00 |
| Mar 31, 2023 | -281.00 |
| Dec 31, 2022 | 2,212.00 |
| Sep 30, 2022 | 2,124.00 |
| Jun 30, 2022 | 1,517.00 |
| Mar 31, 2022 | 1,121.00 |
| Dec 31, 2021 | 545.00 |
| Sep 30, 2021 | 976.00 |